Allergan Agrees to Buy Zeltiq for About $2.48B

Features Reuters

Allergan Plc on Monday said it would buy Zeltiq Aesthetics Inc for about $2.48 billion to gain access to its flagship body contouring technology.

Continue Reading Below

The Botox maker agreed to pay $56.50 per Zeltiq share, or a premium of 14.4 percent to the company's Friday close. (Reporting by Natalie Grover in Bengaluru; Editing by Shounak Dasgupta)